The money just keeps rolling out. This was supposed to be seven million shares at $10-12. Look at the size of these suckers!!
Brought to you by Lehman, Lazard, Vector and Fidelity......
Wednesday August 2, 8:32 pm Eastern Time
Press Release
SOURCE: Rosetta Inpharmatics, Inc.
Rosetta Inpharmatics, Inc. Announces Initial Public
Offering
KIRKLAND, Wash., Aug. 2 /PRNewswire/ -- Rosetta Inpharmatics, Inc. announced today the pricing of its initial public
offering of 7,200,000 shares of common stock at a price of $14 per share. This price is above the original filing range of
$10-$12. The offering is being lead managed by Lehman Brothers and co-managed by Lazard Freres & Co. LLC, Prudential
Vector Healthcare Group, a unit of Prudential Securities, and Fidelity Capital Markets, a division of National Financial Services
Corporation. Rosetta's shares have been approved for quotation on the Nasdaq Stock Market under the symbol ``RSTA.''
Rosetta Inpharmatics, Inc. (Nasdaq: RSTA - news) offers solutions to the emerging field of informational genomics. By
combining the power of informatics and genomics, Rosetta has created a proprietary platform that accelerates and enhances the
drug discovery process for pharmaceutical and biotechnology companies, and improves agricultural products. Rosetta
Inpharmatics' approach converts the rapidly growing amount of gene expression data, or information about a gene's activity,
into organized, statistically driven, information- based results. Rosetta Inpharmatics provides a proprietary gene expression
profiling platform, consisting of hardware and software products, that uses gene expression profiles to provide seamless
solutions for efficient, cost- effective and powerful discovery programs. Rosetta Inpharmatics' technology builds a critical mass
of coherent gene expression data collected from DNA microarrays, which are comprised of DNA fragments attached to glass
slides in a grid-like formation. This platform provides comprehensive, simultaneous descriptions of a compound's effect on all
relevant targets within a cell.
Copies of the final prospectus relating to the initial public offering may be obtained from the Prospectus Department, Lehman
Brothers, c/o ADP Financial Services, Prospectus Fulfillment, 55 Mercedes Way, Edgewood, NY 11717, phone (631)
254-7106, fax (631) 254-7268, Prudential Securities, 111 8th Avenue, 5th Floor, New York, NY 10011, (212) 776-8190,
and Lazard Freres & Co. LLC, 30 Rockefeller Plaza, New York, NY 10020, (212) 632-6000.
SOURCE: Rosetta Inpharmatics, Inc. |
